Published in Cancer Weekly, December 12th, 2006
The study, led by Julie Saba, MD, PhD is the first to link the SPL enzyme to cancer, and it appears in a recent issue of the Proceedings of the National Academy of Sciences. Researchers identified SPL as a key regulator of cancer cells. They discovered that if the cancer cells...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.